Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Revenue

Benitec Biopharma had revenue of $7.00K in the twelve months ending March 31, 2024, down -89.71% year-over-year. In the fiscal year ending June 30, 2023, Benitec Biopharma had annual revenue of $75.00K with 2.74% growth.

• Revenue (ttm): $7.00K
• Revenue Growth: -89.71%
• P/S Ratio: 11,642.44
• Revenue / Employee: $438
• Employees: 16
• Market Cap: 81.50M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	75.00K	2.00K	2.74%
Jun 30, 2022	73.00K	14.00K	23.73%
Jun 30, 2021	59.00K	-43.00K	-42.16%
Jun 30, 2020	102.00K	-12.10M	-99.16%
Jun 30, 2019	12.20M	9.09M	291.99%
Jun 30, 2018	3.11M	-4.44M	-58.81%
Jun 30, 2017	7.56M	4.73M	167.39%
Jun 30, 2016	2.83M	57.15K	2.06%
Jun 30, 2015	2.77M	2.35M	564.21%
Jun 30, 2014	416.81K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.